Age-related and regional differences in dopamine transporter mRNA expression in human midbrain

Neurology

Volumn 48, Issue 4, 1997, Pages 969-977

  Bannon, Michael J ^a   Whitty, Christopher J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; BRAIN REGION; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MESENCEPHALON; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 0030975635     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.4.969     Document Type: Article

References (26)

1. Chiodo LA. Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology. Neurosci Biobehav Rev 1988;12:49-91.
2. Bannon MJ, Granneman JG, Kapatos G. The dopamine transporter: potential involvement in neuropsychiatric disorders. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995; 179-188.
3. Shimada S, Kitayama S, Walther D, Uhl G. Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Brain Res Mol 1992;13:359-362.
4. Cerruti C, Walther DM, Kuhar MJ, Uhl GR. Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. Brain Res Mol 1993;18:181-186.
5. Sanghera MK, Manaye KF, Liang C-L, Iacopino AM, Bannon MJ, German DC. Low dopamine transporter mRNA levels in midbrain regions containing calbindin. Neuroreport 1994;5: 1641-1644.
6. Blanchard V, Raisman-Vozari R, Vyas S, et al. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon. Brain Res Mol 1994;22:29-40.
7. Berger B, Gaspar P, Verney C. Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci 1991;14:21-27.
8. Hurd YL, Pristupa ZB, Herman MM, Niznik HB, Kleinman JE. The dopamine transporter and dopamine D2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons. Neuroscience 1994;63:357-362.
9. Uhl GR, Walther D, Mash D, Faucheux B, Javoy-Agid F. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons. Ann Neurol 1994;35: 494-498.
10. Bannon MJ, Poosch MS, Xia Y, Goebel DJ, Cassin B, Kapatos G. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc Natl Acad Sci USA 1992;89:7095-7099.
11. Zelnick N, Angel I, Paul SM, Kleinman JE. Decreased density of human striatal dopamine uptake sites with age. Eur J Pharmacol 1986;126:175-176.
12. De Keyser J, Ebinger G, Vauquelin G. Age-related changes in the human nigrostriatal dopaminergic system. Ann Neurol 1990;27:157-161.
13. Volkow ND, Fowler JS, Wang GJ, et al. Decreased dopamine transporters with age in healthy human subjects. Ann Neurol 1994;36:237-239.
14. Van Dyck CH, Seibyl JP, Malison RT, et al. Age-related decline in striatal dopamine transporter binding with iodine-123-B-CIT SPECT. J Nucl Med 1995;36:1175-1181.
15. McGeer PL, McGeer EG, Suzuki JS. Aging and extrapyramidal function. Arch Neurol 1977;34:33-35.
16. Whitty CJ, Waker PD, Goebel DJ, Poosch MS, Bannon MJ. Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra. Neuroscience 1995;64:419-425.
17. Whitty CJ, Bannon MJ. Dopamine transporter mRNA levels in human midbrain: regional heterogeneity and changes with age. Soc Neurosci Abstr 1995;21:374.
18. Halliday GM, Tork I. Comparative anatomy of the ventromedial mesencephalic tegmentum in the rat, cat, monkey and human. J Comp Neurol 1986;252:423-445.
19. Mann DMA. Dopamine neurons of the vertebrate brain: some aspects of anatomy and pathology. In: Winslow W, Markstein R, eds. The neurobiology of dopamine systems. Manchester: Manchester University Press, 1984;87-103.
20. Thiesen B, Rajput AH, Laverty W, Desai H. Age, environments, and the number of substantia nigra neurons. Adv Neurol 1990;53:201-206.
21. Tooyama I, McGeer EG, Kawamata T, Kimura H, McGeer PL. Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during aging in humans contrasts with loss in Parkinson's disease. Brain Res 1994;656:165-168.
22. Wolf ME, LeWitt PA, Bannon MJ, Dragovic LJ, Kapatos G. Effect of aging on tyrosine hydroxylase protein content and the relative number of dopamine nerve terminals in human caudate. J Neurochem 1991;56:1191-1200.
23. Moody CA, Granneman JG, Bannon MJ. Dopamine transporter binding in rat striatum and nucleus accumbens is unaltered following chronic changes in dopamine levels. Neurosci Lett 1996;217:55-57.
24. Kish SJ, Shannak K, Rajput A, Deck JHN, Hornykiewicz O. Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. J Neurochem 1992;58:642-648.
25. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996;379: 606-612.
26. Donovan DM, Vandenbergh DJ, Perry MP, et al. Human and mouse dopamine transporter genes: conservation of 5′-flanking sequence elements and gene structures. Brain Res Mol 1995;30:327-335.